ARCHIVES

EGFR Inhibitor Shrinks Tumors In Phase I Study of Patients With Treatment-Resistant Mutation

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Plans Contract To Study Cancer Research Manpower Needs; Epidemiologist State Their Case

October 7, 1977

US Oncology To Participate In Firm’s Ovarian Cancer Trial.

January 26, 2001

EU Gives Marketing Approval For HBV Sequencing Test

April 29, 2011

Chemopreventive Phase I, Preclinical Studies Concept Approved

May 13, 1983

In Brief: Judge Rules FDA Modernization Act Violates First Amendment Over Publications Policy

August 6, 1999

Henry Neil, Natcher’s right arm, Back In The Job

March 25, 1988